A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands

Biochemical Pharmacology

Volumn 81, Issue 9, 2011, Pages 1145-1151

  Matsukawa, Jun ^a   Hori, Yasunobu ^a   Nishida, Haruyuki ^a   Kajino, Masahiro ^a   Inatomi, Nobuhiro ^a  

^a TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Gastric glands; H+K+ ATPase; Lansoprazole; P CAB; TAK 438

Indexed keywords

CARBON 14; FORSKOLIN; LANSOPRAZOLE; POTASSIUM COMPETITIVE ACID BLOCKER; TAK 438; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; STOMACH ACID SECRETION; STOMACH GLAND;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ANTI-ULCER AGENTS; CELLS, CULTURED; H(+)-K(+)-EXCHANGING ATPASE; POTASSIUM; PYRROLES; RABBITS; STOMACH; SULFONAMIDES;

EID: 79953716223     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.02.009     Document Type: Article

References (37)

1. +)-ATPase by proton pump inhibitors J Am Chen Soc 126 2004 7800 7811 (Pubitemid 38812770)
2. S. Shi, and U. Klotz Proton pump inhibitors: an update of their clinical use and pharmacokinetics Eur J Clin Pharmacol 64 2008 935 951
3. M. Tonini, R. De Giorgio, and F. De Ponti Novel therapeutic strategies in acid-related disorders Expert Opin Ther Pat 13 2003 639 649 (Pubitemid 36622217)
4. J. Mossner, and K. Caca Developments in the inhibition of gastric acid secretion Eur J Clin Invest 35 2005 467 534
5. T. Andersson, J. Holmberg, K. Rohss, and A. Walan Pharmacokinetics and effect on caffeine metabolism of the proton pump inhibitors, omeprazole, lansoprazole, and pantoprazole Br J Clin Pharmacol 45 1998 369 375 (Pubitemid 28138829)
6. U. Klotz, M. Schwab, and G. Treiber CYP2C19 polymorphism and proton pump inhibitors Basic Clin Pharmacol Toxicol 95 2004 2 8 (Pubitemid 38993131)
7. P.O. Katz, J.G. Hatlebakk, and D.O. Castell Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole Aliment Pharmacol Ther 14 2000 709 714 (Pubitemid 30352736)
8. T.L. Ang, and K.M. Fock Nocturnal acid breakthrough: clinical significance and management J Gastroenterol Hepatol 21 Suppl. 5 2006 125 128
9. C. Scarpignato, I. Pelosini, and F. Di Mario Acid suppression therapy: where do we go from here? Dig Dis 24 2006 11 46
10. +-ATPase and acid secretion by SCH 28080, a substituted pyridyl(1,2a)imidazole J Biol Chem 262 1987 2077 2084 (Pubitemid 17102653)
11. +)-ATPase inhibitors SCH 32651 and SCH 28080 Biochem Pharmacol 36 1987 97 104 (Pubitemid 17227218)
12. J.F. Long, P.J. Chiu, M.J. Derelanko, and M. Steinberg Gastric antisecretory and cytoprotective activities of SCH 28080 J Pharmacol Exp Ther 226 1983 114 120 (Pubitemid 13026188)
13. M.D. Ene, T. Khan-Daneshmend, and C.J. Roberts A study of the inhibitory effects of SCH 28080 on gastric secretion in man Br J Pharmacol 76 1982 389 391 (Pubitemid 12039801)
14. K. Andersson, and E. Carlsson Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases Pharm Ther 108 2005 294 307 (Pubitemid 41693765)
15. P.J. Kahrilas, J. Dent, K. Lauritsen, and P. Malfertheiner A randomized, comparative study of three doses of AZD0865 and esomeprazole for healing of reflux esophagitis Clin Gastroenterol Hepatol 5 2007 1385 1391 (Pubitemid 350181597)
16. J. Dent, P.J. Kahrilas, J. Hatlebakk, N. Vakil, H. Denison, and S. Franzen A randomized, comparative trial of a potassium-competitive acid blocker (AZD0865) and esomeprazole for the treatment of patients with nonerosive reflux disease Am J Gastroenterol 103 2008 20 26
17. K. Andersson, and E. Carlsson Potassium-competitive acid blockers: a new approach to acid suppression Gastroenterol Hepatol Annu Rev 1 2006 118 122
18. Y. Hori, A. Imanishi, J. Matsukawa, Y. Tsukimi, H. Nishida, and Y. Arikawa 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N- methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases J Pharmacol Exp Ther 335 2010 231 238
19. + permeability involved in gastric proton pumping Am J Physiol Gastrointest Liver Physiol 28 2001 G786 G797
20. +-ATPase inhibitor SPI-447 Jpn J Pharmacol 82 2000 21 28 (Pubitemid 30098646)
21. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J Biol Chem 66 1925 375 400
22. T. Berglindh, and K.J. Obrink A method for preparing isolated glands from the rabbit gastric mucosa Acta Physiol Scand 96 1976 150 159
23. C.S. Chew, M. Ljungström, A. Smolka, and M.R. Brown Primary culture of secretagogue-responsive parietal cells from rabbit gastric mucosa Am J Physiol 256 1989 G254 G263
24. J. Matsukawa, K. Nakayama, T. Nagao, H. Ichijo, and T. Urushidani Role of ADP-ribosylation factor 6 (ARF6) in gastric acid secretion J Biol Chem 278 2003 36470 36475 (Pubitemid 37139976)
25. T. Berglindh, H.F. Helander, and K.J. Obrink Effects of secretagogues on oxygen consumption, aminopyrine accumulation and morphology in isolated gastric glands Acta Physiol Scand 97 1976 401 414
26. D. Armstrong Gastroesophageal reflux disease Curr Opin Pharmacol 5 2005 589 595 (Pubitemid 41614457)
27. C.S. Chew Forskolin stimulation of acid and pepsinogen secretion in isolated gastric glands Am J Physiol 245 5 Pt 1 1983 C371 C380
28. I.L.P. Beales, and J. Calam Inhibition of carbachol stimulated acid secretion by interleukin 1β in rabbit parietal cells requires protein kinase C Gut 48 2001 782 789 (Pubitemid 32476978)
29. +)-adenosine triphosphatase by the proton pump inhibitor AG-1749 J Pharmacol Exp Ther 248 1989 799 805 (Pubitemid 19090257)
30. H. Nagaya, H. Satoh, and Y. Maki Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells J Pharmacol Exp Ther 252 1990 1289 1295 (Pubitemid 20127442)
31. +-ATPase recycling in the gastric parietal cell J Physiol 532 2001 287 296 (Pubitemid 32390388)
32. A. Gerbino, A.M. Hofer, B.M. McKay, B.W. Lau, and D.I. Soybel Divalent cations regulate acidity within the lumen and tubulovesicle compartment of gastric parietal cells Gastroenterology 126 2004 182 195 (Pubitemid 38040735)
33. +-ATPase activity in isolated gastric glands Am J Physiol 252 1987 G458 G465
34. +-competitive inhibitor TAK-438 Gastroenterology 138 2010 S-651-2
35. +-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid scretion Gastroenterology 109 1995 1134 1141
36. M.L. Schubert, and D.A. Peura Control of gastric acid secretion in health and disease Gastroenterology 134 2008 1842 1860 (Pubitemid 351783299)
37. J.M. Shin, K. Munson, O. Vagin, and G. Sachs The gastric HK-ATPase: structure, function, and inhibition Pflugers Arch 457 2009 609 622